Metal Organic Framework (MOF) Particles as Potential Bacteria-Mimicking Delivery Systems for Infectious Diseases: Characterization and Cellular Internalization in Alveolar Macrophages

[1]  P. Couvreur,et al.  Nanoparticles of Metal‐Organic Frameworks: On the Road to In Vivo Efficacy in Biomedicine , 2018, Advanced materials.

[2]  P. Kulinowski,et al.  Iron-Based Metal-Organic Frameworks as a Theranostic Carrier for Local Tuberculosis Therapy , 2018, Pharmaceutical Research.

[3]  Isabel Abánades Lázaro,et al.  Enhancing anticancer cytotoxicity through bimodal drug delivery from ultrasmall Zr MOF nanoparticles. , 2018, Chemical communications.

[4]  M. Bachmann,et al.  Major findings and recent advances in virus-like particle (VLP)-based vaccines. , 2017, Seminars in immunology.

[5]  J. Soleimannejad,et al.  Application of Metal-Organic Framework Nano-MIL-100(Fe) for Sustainable Release of Doxycycline and Tetracycline , 2017, Nanomaterials.

[6]  Alibakhsh Kasaeian,et al.  Biomimetics in drug delivery systems: A critical review , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[7]  D. Fairen-jimenez,et al.  Selective Surface PEGylation of UiO-66 Nanoparticles for Enhanced Stability, Cell Uptake, and pH-Responsive Drug Delivery , 2017, Chem.

[8]  Ting Cai,et al.  In Vivo Targeting and Positron Emission Tomography Imaging of Tumor with Intrinsically Radioactive Metal-Organic Frameworks Nanomaterials. , 2017, ACS nano.

[9]  M. V. Lozano,et al.  Chitosan-coated mesoporous MIL-100(Fe) nanoparticles as improved bio-compatible oral nanocarriers , 2017, Scientific Reports.

[10]  J. Champion,et al.  Tunable particles alter macrophage uptake based on combinatorial effects of physical properties , 2017, Bioengineering & translational medicine.

[11]  Gang Liu,et al.  Engineering Phototheranostic Nanoscale Metal-Organic Frameworks for Multimodal Imaging-Guided Cancer Therapy. , 2017, ACS applied materials & interfaces.

[12]  D. Fairen-jimenez,et al.  Endocytosis Mechanism of Nano Metal‐Organic Frameworks for Drug Delivery , 2016, Advanced healthcare materials.

[13]  Joachim O. Rädler,et al.  Imparting Functionality to MOF Nanoparticles by External Surface Selective Covalent Attachment of Polymers , 2016 .

[14]  C. Lehr,et al.  Invasin-functionalized liposome nanocarriers improve the intracellular delivery of anti-infective drugs , 2016 .

[15]  J. Huskens,et al.  The effect of PEG length on the size and guest uptake of PEG-capped MIL-88A particles. , 2016, Journal of materials chemistry. B.

[16]  C. Lehr,et al.  Bacteriomimetic invasin-functionalized nanocarriers for intracellular delivery. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[17]  S. Kuwabata,et al.  Mannose-displaying fluorescent framboidal nanoparticles containing phenylboronic acid groups as a potential drug carrier for macrophage targeting. , 2015, Colloids and surfaces. B, Biointerfaces.

[18]  A. Jones,et al.  Mycolic acids, a promising mycobacterial ligand for targeting of nanoencapsulated drugs in tuberculosis. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[19]  Hamidreza Ghandehari,et al.  Nanoparticle Uptake: The Phagocyte Problem. , 2015, Nano today.

[20]  Wies van Roosmalen,et al.  Metal-Organic Frameworks (MOFs) as Multivalent Materials: Size Control and Surface Functionalization by Monovalent Capping Ligands. , 2015, Chemistry.

[21]  A. Aykaç,et al.  A “green” strategy to construct non-covalent, stable and bioactive coatings on porous MOF nanoparticles , 2015, Scientific Reports.

[22]  P. Netti,et al.  Energy independent uptake and release of polystyrene nanoparticles in primary mammalian cell cultures. , 2015, Experimental cell research.

[23]  Benjamin Michen,et al.  Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages , 2014, Beilstein journal of nanotechnology.

[24]  D. Putnam,et al.  Pathogen-like particles: biomimetic vaccine carriers engineered at the nanoscale. , 2014, Current opinion in biotechnology.

[25]  G. Gompper,et al.  Shape and orientation matter for the cellular uptake of nonspherical particles. , 2014, Nano letters.

[26]  H. Willaime,et al.  Towards an Improved anti‐HIV Activity of NRTI via Metal–Organic Frameworks Nanoparticles , 2013, Advanced healthcare materials.

[27]  Samir Mitragotri,et al.  Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium , 2013, Proceedings of the National Academy of Sciences.

[28]  Ruxandra Gref,et al.  In depth analysis of the in vivo toxicity of nanoparticles of porous iron(III) metal–organic frameworks , 2013 .

[29]  Ana E. Platero‐Prats,et al.  Green Microwave Synthesis of MIL‐100(Al, Cr, Fe) Nanoparticles for Thin‐Film Elaboration , 2012 .

[30]  Balaji Narasimhan,et al.  Tailoring the immune response by targeting C-type lectin receptors on alveolar macrophages using "pathogen-like" amphiphilic polyanhydride nanoparticles. , 2012, Biomaterials.

[31]  Seungjae Kim,et al.  Phagocytosis and Endocytosis of Silver Nanoparticles Induce Interleukin-8 Production in Human Macrophages , 2012, Yonsei medical journal.

[32]  Gérard Férey,et al.  Metal-organic frameworks in biomedicine. , 2012, Chemical reviews.

[33]  J. Long,et al.  Introduction to metal-organic frameworks. , 2012, Chemical reviews.

[34]  D. Irvine,et al.  Bio-inspired, bioengineered and biomimetic drug delivery carriers , 2011, Nature Reviews Drug Discovery.

[35]  Ruxandra Gref,et al.  Optimisation of the synthesis of MOF nanoparticles made of flexible porous iron fumarate MIL-88A , 2011 .

[36]  Seda Keskin,et al.  Biomedical Applications of Metal Organic Frameworks , 2011 .

[37]  Z. Su,et al.  Particle size affects the cellular response in macrophages. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[38]  P. Couvreur,et al.  BioMOFs: metal-organic frameworks for biological and medical applications. , 2010, Angewandte Chemie.

[39]  Murugesan V. S. Rajaram,et al.  Mycobacterium tuberculosis Activates Human Macrophage Peroxisome Proliferator-Activated Receptor γ Linking Mannose Receptor Recognition to Regulation of Immune Responses , 2010, The Journal of Immunology.

[40]  Wenbin Lin,et al.  Metal-organic frameworks as potential drug carriers. , 2010, Current opinion in chemical biology.

[41]  Gérard Férey,et al.  Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. , 2010, Nature materials.

[42]  T. Irimura,et al.  Macrophage Receptors for Influenza A Virus: Role of the Macrophage Galactose-Type Lectin and Mannose Receptor in Viral Entry , 2010, Journal of Virology.

[43]  Zhigang Xie,et al.  Postsynthetic modifications of iron-carboxylate nanoscale metal-organic frameworks for imaging and drug delivery. , 2009, Journal of the American Chemical Society.

[44]  R. Valdivia,et al.  Leading a sheltered life: intracellular pathogens and maintenance of vacuolar compartments. , 2009, Cell host & microbe.

[45]  Hong‐Cai Zhou,et al.  Selective gas adsorption and separation in metal-organic frameworks. , 2009, Chemical Society reviews.

[46]  S. Nguyen,et al.  Metal-organic framework materials as catalysts. , 2009, Chemical Society reviews.

[47]  Dan Zhao,et al.  The current status of hydrogen storage in metal–organic frameworks , 2008 .

[48]  Alistair C. McKinlay,et al.  Exceptional behavior over the whole adsorption-storage-delivery cycle for NO in porous metal organic frameworks. , 2008, Journal of the American Chemical Society.

[49]  Samir Mitragotri,et al.  Role of Particle Size in Phagocytosis of Polymeric Microspheres , 2008, Pharmaceutical Research.

[50]  L. Dixon,et al.  Macrophage Transcriptional Responses following In Vitro Infection with a Highly Virulent African Swine Fever Virus Isolate , 2006, Journal of Virology.

[51]  Samir Mitragotri,et al.  Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[52]  C. Espitia,et al.  The 19-kDa antigen of Mycobacterium tuberculosis is a major adhesin that binds the mannose receptor of THP-1 monocytic cells and promotes phagocytosis of mycobacteria. , 2005, Microbial pathogenesis.

[53]  E. Königsberger,et al.  Complexation of iron(III) and iron(II) by citrate. Implications for iron speciation in blood plasma. , 2000, Journal of inorganic biochemistry.

[54]  A. Limper,et al.  Alveolar macrophage interactions with Pneumocystis carinii. , 1999, The Journal of laboratory and clinical medicine.

[55]  Samuel I. Miller,et al.  How intracellular bacteria survive: surface modifications that promote resistance to host innate immune responses. , 1999, The Journal of infectious diseases.

[56]  Q. Eichbaum,et al.  Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation. , 1998, The Journal of clinical investigation.

[57]  N. Sharon,et al.  Lectinophagocytosis of encapsulated Klebsiella pneumoniae mediated by surface lectins of guinea pig alveolar macrophages and human monocyte-derived macrophages , 1991, Infection and immunity.

[58]  V. Shepherd,et al.  Purification of the human alveolar macrophage mannose receptor. , 1987, Biochemical and biophysical research communications.

[59]  S. Szu,et al.  Chemical structure of and immune response to polysaccharides of Streptococcus pneumoniae. , 1981, Reviews of infectious diseases.

[60]  J. Hartley,et al.  Chemical and Physical Properties of Lipopolysaccharide of Yersinia pestis , 1974, Journal of bacteriology.

[61]  F. Ahsan,et al.  Particle engineering to enhance or lessen particle uptake by alveolar macrophages and to influence the therapeutic outcome. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[62]  Tabaran Flaviu,et al.  Macrophages Targeted Drug Delivery as a Key Therapy in Infectious Disease , 2014 .

[63]  Efstathios Karathanasis,et al.  Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles. , 2014, Nanomedicine.

[64]  S Gordon,et al.  Macrophage receptors and immune recognition. , 2005, Annual review of immunology.